Point72 Asset Management »

Tourmaline Bio shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.7M 338k 25.71

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Shell Spon Ads (SHEL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Arista Networks (ANET)
Comcast Corp Cl A (CMCSA)
Boston Scientific Corporation (BSX)
M/a (MTSI)
Lumentum Hldgs (LITE)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl A (GOOGL)
ConocoPhillips (COP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Tourmaline Bio

RA Capital Management
BlackRock
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
QVT Financial
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Point72 Asset Management
State Street Corporation
Morgan Stanley

View all funds holding Tourmaline Bio